Aug 31, 2020

Aubrey de Grey | Keynote Speech

Posted by in categories: biotech/medical, neuroscience

In his keynote speech at Ending Age-Related Diseases 2020, Dr. Aubrey de Grey of SENS Research Foundation discusses the current state of the rejuvenation biotechnology industry in the context of the current pandemic. He mentions the failure of Unity Biotechnology’s Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization of rejuvenation biotechnology, XPRIZE, and the steps that are currently being taken towards a world without age-related diseases.

LEAF / is a 501©(3) nonprofit organization. Everything we’ve done thus far and everything we will do in the future is thanks to your support — please stand with us to fight the diseases of aging and increase healthy human lifespan.
► Support us with monthly donations by becoming a Lifespan Hero:
► Make a one-time donation and learn about other ways to support us here:
► Learn more, and help us #CrowdsourceTheCure:
► Subscribe:

Join us, and together, we can overcome diseases like Alzheimer’s, heart disease, and cancer by addressing their shared source: the aging processes themselves.

#Research #Aging #Funding #LEAF #Conference

Comments are closed.